in the rat, rabbit, and man {1-3). Further studies (4, 5) have indicated the involvement of three microsomal enzymes in the novel metabolic pathway. The mercaptan sulfur is first methylated by S-transmethylase in the presence of S-adenosylmethionine to yield methyl tetrahydrofurfuryl sulfide (MTFS). The resultant sulfide is oxidized to methyl tetrahydrofurfuryl sulfoxide (MTFSO) by sulfide oxygenase and further to the correspond-ing sulfone (MTFSO 2 ) by sulfoxide oxygenase. These three drug-metabolizing enzymes are most abundant in the liver and are exclusively localized in microsomes.
The latter two enzymes, which required NADPH and O 2 , have been shown to be typical mono-oxygenases by means of 1B oxygen experiments (5) . This finding may be the first indication that mono-oxygenase-type enzymes participate in the oxidation of foreign sulfur. At present, TTFD is widely used as a thiamine substitute or therapeutic agent. It seems therefore pertinent to obtain some data on the induction of these novel enzymes during daily medication or concomitant administration with other drugs. The present studies have been undertaken to investigate whether these microsomal enzymes relating to sulfur metabolism could be induced in rats pretreated with phenobarbital, 3-methylcholanthrene, the substrates or TTFD. The results thus obtained indicate that phenobarbital causes remarkable induction of both oxygenase activities whereas 3-methylcholanthrene causes a slight induction of S-transmethylase activity. On the other hand, pretreatment with the substrates or related compounds failed to induce these enzyme activities. 3 ]methionine (3.3 £*Ci/mmole) was synthesized enzymatically, as described previously (4) . All other reagents were of the highest grade available commercially.
METHODS

Materials
Treatment of Rats-Sprague-Dawley rats (SD-JCL), maintained on a usual laboratory chow (CE-2, Japan CLEA, Inc.) were used for the present studies. Sex and body weight are described with the respective results.
The drugs were injected intraperitoneally into rats, once daily at 9 a.m. Control rats received saline or corn oil. The dosing conditions were as follows. 1) Sodium phenobarbital (5% in saline), lOOmg/kg body weight, 4 days; 2) 3-methylcholanthrene (1% in corn oil), 20mg/kg, 3 days; 3) TTFD HC1 (0.3% and 5% in saline), 3 and 50mg/kg, 8 days, respectively; 4) thiamine HC1, TTFD HC1, TFSH, MTFS, MTFSO, or MTFSO 2 (0.05 mM in saline), 0.1 mmole/kg, 7 days. In another experiment, TTFD HC1 was mixed with the powdered diet .(CE-2) at 0.1% (w/w). Rats were fed on the diet ad libitum for 4 weeks. The average intake of TTFD was about 20 mg/day/rat.
Preparation of Microsomes-The pretreated rats were sacrificed by decapitation 24 hr after the last injection. After the animals were exsanguinated, the livers were excised, homogenized and subjected to differential centrifugation as described previously (4) . Microsomal fractions sedimented between the two centrifugal procedures of 10,000xg-10min and 105,000xg-60min were used for the subsequent enzyme assays on the day of their preparation.
Enzyme Assay-The standard assay condition for S-transmethylase, and sulfide and sulfoxide oxygenases were fully described in our previous reports {4, 5) . The principle is based on determining the amounts of products formed from the respective radioactive substrates. The products were separated from the substrates by thin layer chromatography and the radioactivity was measured by liquid scintillation counting.
Aniline hydroxylase [EC 1.14.1.1] and aminopyrine N-demethylase activities were determined by measuring the oxidized prod-ucts, £-aminophenol and formaldehyde, respectively. Enzyme reactions were performed at 30°C for 20min in a medium containing 100 mM Tris-HCl buffer, pH 7.4, 50 mM nicotinamide, lmM NADP+, 20 mM glucose 6-phosphate, 5mM MgCl 2 , glucose-6-phosphate dehydrogenase, microsomes (ca. 5 to 6mg protein), and 10 mM of each substrate in a total volume of 2.0 ml. The NADPH-generating system possessed sufficient activity to reduce 3 A< moles of NADP + /min. />-Aminophenol was determined by the method of Imai et al. (6) . The enzyme reaction was terminated by the addition of 1 ml of 20% trichloroacetic acid. After deproteinization by centrifugation (3,000 rpm for lOmin), lml of the supernatant was added to 1 ml of 1M Na 2 CO 3 and mixed with 1 ml of 2% phenol in 0.5 N NaOH. After incubation (30°C, 15min), the blue color was determined at 630 m/*. For assay of aminopyrine N-demethylase, formaldehyde was estimated by colorimetry. After addition of 0.5 ml of 10% trichloroacetic acid, the reaction mixture was deproteinized by centrifugation and 1.5 ml of the supernatant was mixed with 1.5ml of Nash reagent B (7), and incubated at 58°C for 5min. After cooling to room temperature, the yellow color was determined at 412 m//.
NADPH-cytochrome c reductase activity was measured spectrophotometrically using a Beckman DB recording spectrophotometer at room temperature, according to Philips and Langdon (8) with a slight modification. The reaction mixture contained 100 mM Tris-HCl buffer, pH 7.4, the above NADPH-generating system, lmM KCN, 5.1xlO" 5 M cytochrome c, and microsomes in a total volume of 2.0 ml. Changes at 550 mp were recorded and the amounts of reduced cytochrome c were estimated on the basis of an extinction coefficient of lSimM-^cm" 1 (9) . Analytical Procedures-Microsomal contents of cytochromes P-450 and b$ were determined spectrophotometrically by using a Perkin-Elmer, model 450 recording spectrophotometer according to the method of Omura and Sato (10) . Extinction coefficients of 91 mM-'-cm" 1 at 450 to 490m^, and 185mM" 1 ' cm" 1 at 426 to 410 mp were used for the estimation of cytochrome P-450 and cytochrome h, respectively. Protein was determined by the method of Lowry et al. (11) with bovine serum albumin (Sigma Chemical) as a standard.
Statistical analysis was done using Student's t-test. Differences with P values of <0.05 were defined as "significant."
RESULTS AND DISCUSSION
Sex Difference-As a preliminary experiment, sex differences in the activities of Stransmethylase, and sulfoxide oxygenases were examined using Sprague-Dawley rats at the age of 6 weeks. These enzyme activities, particularly sulfoxide oxygenase, were significantly higher in males than in females (Table I ). The levels of aniline hydroxylase, aminopyrine N-demethylase, and cytochrome P-450 were also higher in males but no sex difference was observed with NADPH-cytochrome c reductase and cytochrome b 5 . These results are consistent with those reported by other investigators (12, 13) . In the following induction experiments, only male rats were used.
Phenobarbital Treatment -Liver weight and microsomal protein content were increased after phenobarbital treatment but body weight gain was not changed during the treatment (Table II) . Although S-transmethylase activity was not altered, the activities of both sulfide and sulfoxide oxygenases were enhanced 2-fold by phenobarbital treatment. Other microsomal enzymes relating to drug metabolism were likewise induced by phenobarbital, as already reported by other investigators (14, 15) . The present results are in good agreement with the well-known finding that phenobarbital is a potent and versatile inducer of drug-metabolizing enzymes (16, 17) .
3-Methylcholanthrene Treatment-A slight but significant induction of S-transmethylase activity was observed after a 3-day treatment with 3-methylcholanthrene (Table III) . No significant alteration was observed in sulfide and sulfoxide oxygenases or in aminopyrine N-demethylase and NADPH-cytochrome c reductase. On the other hand, the levels of cytochromes P-450 and 6 5 the same treatment. In this respect, our results are consistent with the current view that 3-methylcholanthrene is a rather specific inducer for limited types of drug metabolizing enzymes (16, 17) . T TFD Treatment--Treatment with TTFD had no inducing effect on all the tested microsomal enzymes after 8-day administration with an injected dose of either 3 or 50 mg/kg (Table  IV) . Body weight gain, liver weight, and protein content of liver microsomes were not affected by successive administration of TTFD. The inability of TTFD to induce the microsomal enzymes was similarly indicated when TTFD was administered orally for 4 weeks with the diet (Table V) .
Treatment with TTFD and Related Metabolites--Rats were intraperitoneally injected daily for 7 days with 0.1 mmoles/kg of thiamine, TTFD, and related metabolites including TFSH, MTFS, MTFSO, or MTFSO 2 . TFSH, MTFS, and MTFSO are the substrates for Stransmethylase, sulfide and sulfoxide oxygenases, respectively. Treatment with these compounds did not cause any marked alteration in the microsomal enzymes (Table VI) . STransmethylase activity was slightly increased by treatment with thiamine, MTFS, MTFSO, and MTFSO 2 . Statistical analysis could not be applied to these data, because the enzyme activity was assayed on the pooled liver from 5 rats in this experiment. A trend of slight induction was also observed with aniline hydroxylase after treatment with TFSH or MTFSO as well as for aminopyrine N-demethylase after administration of thiamine, TTFD, or TFSH. On the other hand, both sulfide and sulfoxide oxygenases appeared to be somewhat depressed after MTFSO 2 treatment. Although statistical analysis could not be carried out due to the same reason mentioned above, it might be concluded that TTFD and related metabolites failed to cause any appreciable change in the tested enzyme activities. This is supported by the fact that no significant effect could be recognized on either liver weight or its ratio to body weight, as proved by Student's t-test.
To summarize the present paper, treatment with TTFD or related metabolites caused little or no induction of S-transmethylase, and sulfide and sulfoxide oxygenases, which are responsible for the biotransformation of the TFSH moiety of TTFD in the rat. On the other hand, both oxygenases could be induced by phenobarbital, a potent inducer stimulating the metabolism of a variety of drugs, whereas S-transmethylase was induced by 3-methylcholanthrene, an inducer for only a limited number of drug metabolizing enzymes. 
